Healthcare Equipment and Supplies
Company Overview of CooperVision, Inc.
CooperVision, Inc. engages in the manufacture and distribution of contact lenses. The company specializes in lenses for astigmatism, presbyopia, and ocular dryness serving practitioners and patients. It offers contact lens materials and optics, including naturally wettable silicone hydrogel lenses; spherical, toric, and multifocal products; and monthly, two-week, and daily disposable contact lenses. CooperVision, Inc. was formerly known as Cooper Laboratories and changed its name to CooperVision, Inc. in January 1979. The company was founded in 1958 and is based in Fairport, New York with an additional office in Pleasanton, California. CooperVision, Inc. operates as a subsidiary of The Coope...
370 Woodcliff Drive
Fairport, NY 14450
Founded in 1958
Key Executives for CooperVision, Inc.
President and Chief Operating Officer
Chief Executive Officer of Cooper Companies
Executive Vice President of Global Commercial Strategy and President of Americas
President of Coopervision US
Compensation as of Fiscal Year 2014.
CooperVision, Inc. Key Developments
CooperVision Reports Revenue Results for the First Quarter Ended January 31, 2014; Revises Revenue Guidance for the Fiscal Year 2014
Mar 6 14
CooperVision reported revenue results for the first quarter ended January 31, 2014. For the quarter, the company reported revenue up 8% to $326.3 million, up 14% in constant currency and excluding the divestiture of Aime.
For the fiscal year 2014, the company expected revenues to be in the range of $1,365 million to $1,395 million compared to previously expected revenues of $1,355 million to $1,395 million.
CooperVision, Inc. Announces Executive Changes
Jan 10 14
CooperVision, Inc. announced that John Weber will resign as President and transition to Executive Vice President of the company effective February 1, 2014. On February 1, 2014, Daniel McBride, Chief Operating Officer of The Cooper Companies, Inc. will assume the additional role of President of the company.
CooperVision Launches Biofinity(R) XR Contact Lenses
Oct 21 13
CooperVision Inc. announced the launch of its Biofinity(R) XR contact lens brand. This is an extension to its popular Biofinity (comfilcon A) silicone hydrogel technology, allowing practitioners to confidently fit a greater number of monthly replacement lens patients, including those with significant hyperopia and myopia. The Biofinity XR lens is the first of its kind that combines high oxygen permeability with all-day comfort characteristics required for wearers with more demanding prescriptions. With Biofinity XR, more people can enjoy the benefits of modern contact lens material and design, helping them live life without the hassle of glasses. Biofinity XR lenses are now available in powers from +8.50 to +15.00 (0.50 steps) and -12.50 to -20.00 (0.50 steps). The current Biofinity line continues to be available in +8.00 to -12.00 powers.
Similar Private Companies By Industry
Recent Private Companies Transactions
|No transactions available in the past 12 months.|